Invention Application
- Patent Title: APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
-
Application No.: US15803568Application Date: 2017-11-03
-
Publication No.: US20180140595A1Publication Date: 2018-05-24
- Inventor: Le Wang , George Doherty , Xilu Wang , Zhi-Fu Tao , Milan Bruncko , Aaron R. Kunzer , Michael D. Wendt , Xiaohong Song , Robin Frey , Todd M. Hansen , Gerard M. Sullivan , Andrew Judd , Andrew Souers
- Applicant: AbbVie Inc.
- Main IPC: A61K31/4725
- IPC: A61K31/4725 ; C07D401/04 ; C07D417/14 ; C07D487/04 ; C07D493/08 ; C07D513/04 ; A61K31/5377 ; A61K31/5025 ; A61K31/4985 ; C07D471/04 ; A61K31/541
Abstract:
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-xL protein.
Information query
IPC分类:
